A State-by-State Map of External Review: Where Insurance Denials Actually Get Overturned

The federal floor for external review of a denied health-insurance claim was set in 2010 at 45 CFR 147.136, and on paper it looks like a single national standard. In practice, every state runs the program differently, and the spread in published reversal rates is wider than almost any other consumer-protection variance the NAIC reports. The Connecticut Insurance Department's most recent annual external-review report puts the combined overturn rate at roughly four in five cases filed. West Virginia's most recent posted figure runs near 17 percent. The denial letter does not change at the state line. The clinical record does not change. The odds change, and the change is enormous.

This is a working guide for the patient sitting with a final internal denial in hand, trying to figure out whether external review is worth the next thirty days of paperwork, and where the procedural details actually live for the state on the insurance card. Apellica prepares external-review submissions for a living, so my hand is on the scale. I have tried to flag where.

A note on sources before we start. Every state-level figure here cites the state Department of Insurance annual external-review report or the KFF compilation that tracks them. The federal procedural figures come from eCFR, from CMS, and from the HHS-administered external-review portal at externalappeal.com. ProPublica called external review "one of the industry's best-kept secrets" in its 2023 reporting. The reporting holds up.

The federal floor, and what the state actually controls

The federal external-review rule at 45 CFR 147.136 sets one substantive standard and a small set of procedural minima. The standard is that an Independent Review Organization, with no financial relationship to the carrier, takes a fresh look at the denial and that the IRO decision binds the carrier. The procedural minima are a 4-month filing window from the final internal denial, a 45-day ceiling on a standard decision, and a 72-hour ceiling on an expedited urgent-care decision.

Everything else is set by the state. Which IRO gets the case. Whether the state Department of Insurance runs the intake portal or whether HHS does. Whether the state publishes annual external-review data and how it counts overturned, partially overturned, and modified decisions. The fee, if any, the patient pays at filing. The median time to a standard decision. Whether the state runs a consumer-advocate office that helps patients write the submission. Whether the state regulator follows up on patterns of denial after the IRO has ruled.

That last detail, regulator follow-up, is the most underappreciated lever in the system. A carrier that loses an IRO decision in a state with a published market-conduct program has real downstream exposure. A carrier that loses an IRO decision in a state that does not publish data and does not run market-conduct exams has very little exposure beyond paying the one claim. The published reversal-rate variance reflects partly the patient pool and the carrier mix in each state, and partly how seriously each state regulator polices its IRO output.

The Connecticut number, and why it is real

The Connecticut Insurance Department publishes one of the most detailed external-review annual reports in the country. The most recent posting shows a combined full-reversal and partial-reversal rate near 80 percent across denial categories. The number sits well above the national midpoint that KFF and the NAIC compile, and well above what any IRO-process designer would project from the federal rule text alone. It is not a reporting artifact. The Connecticut Office of the Healthcare Advocate, established in 1999 under the state insurance code, is the operative reason.

The Office of the Healthcare Advocate is a small state agency, funded by a per-life assessment on regulated carriers, with a statutory mission to help Connecticut residents navigate denials and appeals. The office helps patients file internal appeals, helps them file external-review requests, and maintains a denial-letter database that informs the state regulator's market-conduct work. When a Connecticut resident files an external review, the IRO is more likely to receive a submission that has already been triaged for a likely-winning denial archetype, supported by the patient's chart, and aligned with the carrier's own medical-policy bulletin. The reversal rate reflects, in part, that the cases reaching the IRO are pre-filtered.

The Connecticut model is not exotic. Vermont, Maryland, New Jersey, and Massachusetts each operate state-funded or state-housed consumer-advocate functions on similar lines. Massachusetts runs the Office of Patient Protection inside the Health Policy Commission under Massachusetts General Laws Chapter 176O. New Jersey runs the Independent Health Care Appeals Program inside the Department of Banking and Insurance. The pattern, in the states where the data is public, is that a state-funded patient-advocacy intermediary correlates with higher external-review reversal rates and with shorter median time-to-decision. States without that intermediary leave the patient to assemble the IRO submission alone.

The 27-state reporting gap

Twenty-seven state Departments of Insurance do not currently publish a recent annual external-review report with category-level reversal data that a researcher can compare against the federal floor. Some states post a one-page aggregate count. Some post nothing at all. KFF's state-by-state insurance tracker at kff.org/statedata collates what is available, and the gaps are flagged explicitly. The 27-state opacity is the single biggest obstacle to running a clean cross-state comparison.

The West Virginia number cited at the top of this piece comes from a state DOI annual filing that publishes the count but not the category breakdown. The 17 percent figure reflects the denominator the state uses, which differs from the denominator California or Connecticut uses. The directional point holds. Patients in low-reporting, low-reversal states are filing into a system that produces, on the published evidence, materially fewer reversals than the national midpoint.

The federal HHS-administered process, and the six states that use it

Six states currently rely on the HHS-administered external-review process rather than running their own. The list moves over time. Patients should confirm current status by checking healthcare.gov or by calling the federal contractor directly. The intake URL is externalappeal.com. The phone line is +1 (888) 866-6205, which routes requests to MAXIMUS Federal Services under its contract with CMS.

Patients in HHS-administered states are not disadvantaged on substantive merits. The reviewer pool is qualified to the same federal standard. The decision is just as binding. The procedural details differ. The filing portal is national, not local. Median time-to-decision tends to run closer to the 45-day federal ceiling than in the fastest state systems. There is no state-level consumer advocate to triage the submission before it reaches the contractor. The federal track is functional. The procedural overhead falls more heavily on the patient because the state-level scaffolding that exists in the higher-reversal states is absent in this lane.

The deadline anatomy

Across the ACA framework the standard external-review filing deadline is four months from the date of the final internal denial. That floor is in 45 CFR 147.136. States that run their own systems generally adopt the same four-month standard. The clock starts on the date printed on the final internal denial letter, not the date the envelope reached the kitchen counter. Patients who calendar from the receipt date routinely miss the filing window by a week.

For ERISA self-funded plans, the external-review deadline mirrors the ACA standard when the plan has voluntarily adopted ACA-style external review, which most large plans have. When the plan uses a different procedure, the deadline lives in the Summary Plan Description. The 30-day document-request right at 29 CFR 2560.503-1 is the lever that surfaces the SPD when the plan administrator has been slow to produce it. The fee cap on producing those documents is 25 cents per page.

Medicare Advantage runs on its own clock at 42 CFR 422.592, with the case auto-forwarding to the Independent Review Entity rather than depending on the patient to file a new request. The IRE is federal and does not vary by state. Original Medicare Parts A and B run the Qualified Independent Contractor reconsideration at Level 2 under 42 CFR Part 405. Also federal. The state-by-state map below applies to ACA-plan and ERISA-plan external review, which together cover most under-65 commercial insurance in the country.

The published reversal-rate spread

The table below summarizes recent-year published external-review reversal rates from the state Department of Insurance annual reports and from the KFF compilation that tracks them. Reported figures move year to year, denominators differ between jurisdictions, and the ranges below are deliberately wide. Patients investigating their own state's current rate should consult the cited DOI report directly.

| Tier | State system | Published combined overturn rate, recent reporting | Source | |---|---|---|---| | Highest | Connecticut Insurance Department | roughly four in five cases | CT Insurance Department annual report | | High | California DMHC Independent Medical Review | combined overturn well above the national midpoint | DMHC annual IMR report | | High | New York Department of Financial Services | combined overturn above the national midpoint | NY DFS external-appeal annual report | | High | Massachusetts Office of Patient Protection | combined overturn above the national midpoint | OPP annual report | | High | Maryland Insurance Administration | combined overturn above the national midpoint | MIA annual report | | High | New Jersey Independent Health Care Appeals Program | combined overturn above the national midpoint | NJ DOBI IHCAP annual report | | High | Vermont Department of Financial Regulation | combined overturn above the national midpoint | VT DFR annual report | | National midpoint | KFF / NAIC compilation | roughly four in ten to half | KFF, NAIC | | Low | Texas Department of Insurance IRO process | combined overturn below the national midpoint | TDI annual IRO report | | Low | Indiana Department of Insurance | combined overturn below the national midpoint | IDOI reporting | | Lowest | West Virginia Offices of the Insurance Commissioner | roughly one in six cases | WV OIC annual filing | | Reporting gap | 27 states | no recent category-level data published | KFF compilation, state DOI surveys |

The directional point matters more than any single ratio. External review reverses denials more often than internal appeal at the same carrier, the variance between states is large, and the states with the highest published reversal rates almost all run a state-funded patient-advocacy intermediary.

The time-to-decision floor

The ACA framework caps standard external-review decisions at 45 days and expedited decisions at 72 hours. State systems that publish median time-to-decision data generally run inside the ceiling. The fastest state programs close standard cases in three to four weeks.

| State / system | Median days to standard decision | Expedited ceiling | Source | |---|---|---|---| | California DMHC IMR | roughly twenty to thirty days | 72 hours | DMHC IMR statute and annual report | | Massachusetts Office of Patient Protection | roughly twenty-five to thirty-five days | 72 hours | MGL Chapter 176O | | New York DFS external appeal | roughly twenty-five to thirty-five days | 72 hours | NY External Appeal Law | | Connecticut Insurance Department | roughly thirty to forty days | 72 hours | CT Insurance Department | | Texas TDI IRO process | roughly thirty to forty days | 72 hours | Texas Insurance Code Chapter 4202 | | Illinois Department of Insurance | roughly thirty to forty days | 72 hours | Illinois Health Carrier External Review Act | | Federal floor under ACA | up to 45 days | 72 hours | 45 CFR 147.136(d) | | HHS-administered federal track | roughly thirty-five to forty-five days | 72 hours | CMS, CCIIO |

The patient with an urgent-care denial should ask for the expedited 72-hour track explicitly, by phone and in writing, and should ask the treating physician to provide a written attestation that meets the carrier's specific urgency standard. Generic urgency language does not always trigger the expedited clock.

The filing-fee map

Forty-seven states and the District of Columbia charge the patient nothing to file an external-review request. A small number of jurisdictions historically charged a nominal fee, almost always refundable on reversal and waivable for financial hardship. The carrier bears the IRO contractor cost in every state. Patients should verify current fees on the state DOI consumer page before filing.

| State / system | Patient filing fee | Notes | |---|---|---| | California DMHC IMR | none | Statutory | | New York DFS | none to small statutory fee, varies by category | Fee waivable for hardship; refundable on reversal | | New Jersey IHCAP | small statutory fee historically | Refundable on reversal; verify current rule | | Massachusetts Office of Patient Protection | none | No fee | | Connecticut Insurance Department | none | No fee | | Texas TDI IRO process | none to patient | Carrier pays IRO cost | | Illinois Department of Insurance | none | No fee under HCERA | | Florida Office of Insurance Regulation | none | No fee | | HHS-administered federal track | none | Federal contractor cost borne by carrier | | Most other states | none | Carrier pays IRO cost |

The cost barrier to external review, in practice, is not the filing fee. It is the procedural overhead of preparing a submission that the IRO can actually act on.

How the IRO mechanic actually works

The IRO is a private medical-review company under contract to the state DOI, or in the federal track to CMS through MAXIMUS. The state regulator certifies the IRO against the federal standards in 45 CFR 147.136 and a parallel state statute. The IRO is paid by the carrier on a per-case basis, but selected by the regulator, which is the structural feature that gives the process its independence.

When the patient files, the state DOI logs the case and assigns it to an IRO on a rotational basis from a certified roster. The IRO receives the patient's submission, the carrier's claim file, the denial letter, the carrier's medical-policy bulletin, the patient's medical records, and any supporting evidence. The IRO assigns a subspecialty reviewer who reads the record and issues a written decision binding on the carrier. A patient who loses at IRO retains the right to file a civil action under 29 CFR 2560.503-1 for an ERISA plan or under state law for a fully insured plan. The IRO sees a paper record. The patient is no longer in the room. The submission that wins is the submission that meets the reviewer where the reviewer reads.

Why a self-prepared submission usually stalls

External review is the second-look stage where the patient's odds rise the most. It is also the stage where procedural error is the most expensive. The library Apellica has catalogued (more than two hundred carrier-by-denial-type combinations indexed at the medical-policy-bulletin level) each have their own preferred reviewer pool, their own bulletin language, and their own definition of medical necessity. A submission structured for the wrong reviewer audience fails at external review even when the same submission won at internal appeal in a different state.

The 30-day document-request right at 29 CFR 2560.503-1(h)(2)(iii) for ERISA plans and at 45 CFR 147.136(b)(2)(ii)(C) for ACA plans is the last opportunity to compel the carrier to produce the criteria it actually applied. A demand letter without the correct CFR citation gets treated as a courtesy inquiry and stalls. The four-month external-review filing window does not pause while the carrier delays document production. Procedural exhaustion missteps can also foreclose later judicial action under ERISA Section 502(a)(1)(B). The same denial, on the same merits, has different odds in Hartford than in Charleston. The clinical record does not move. The geography does.

Where to ask for help that is free

Free help exists in every state, and the denial letter rarely lists most of it. State Departments of Insurance run consumer-affairs divisions that can file complaints, route external-review requests, and put a regulator in touch with the carrier. The NAIC consumer site at content.naic.org/consumer.htm lists every state contact. The CMS Consumer Assistance Program at cms.gov/CCIIO operates in more than 35 states. KFF's state-by-state insurance tracker at kff.org/statedata is the most widely used non-government compilation. The Patient Advocate Foundation assigns free case managers for complex situations. The Department of Labor's Employee Benefits Security Administration is the right call for ERISA-specific questions. The Connecticut model, the Office of the Healthcare Advocate, exists in roughly the same form in Vermont, Maryland, New Jersey, and Massachusetts; patients in those states should call the state-housed advocate first. Most patients need one of these calls, not all of them.

Where Apellica fits

Apellica prepares the evidence-based external-review submission. Disclosure: this is the firm I work for. The patient reviews and approves every word before submission and authorizes carrier communications under a HIPAA-compliant Assignment of Benefits. We are not a law firm. We are not a medical provider. We are not an insurance carrier. We are an independent administrative service that turns a denied claim into a properly documented external-review submission and tracks it through to the IRO decision.

The model is $0 upfront and a flat fee on successful recovery. If the appeal does not reverse, the patient owes nothing for the preparation work. We cover all 50 states, both state-run and HHS-administered external-review systems, all ACA plans, and ERISA self-funded plans that have adopted ACA-style external review. A senior reviewer reads every case before it goes out. We do not work on cancer, oncology, or rare-disease cases; those belong with subspecialty advocates who do nothing else.

If you do not want to hire anyone, that is fine, and the free resources above are real. If you want a draft prepared by a desk that has indexed external-review behavior in every state-run and HHS-administered jurisdiction, that is what we do.

If you are sitting on a final internal denial right now

The next 48 hours after a final internal denial arrives matter more than the next four months. Find the date in the upper right corner of the letter. Calendar four months from that date. Identify whether your plan is ACA Marketplace, ERISA self-funded, Medicare Advantage, or Original Medicare; the external-review process for the first two is the subject of this piece, and the second two run on the federal IRE or QIC track instead. Check whether your state runs its own external-review system or relies on the HHS-administered federal track at externalappeal.com or +1 (888) 866-6205. Pull your state DOI's external-review request form. Request the carrier's medical-policy bulletin and the criteria applied. Then build the submission.

The published reversal-rate spread is the falsifiable claim in this piece. Connecticut's annual report shows roughly four-in-five overturns. West Virginia's shows roughly one-in-six. The federal floor is identical. The state-level scaffolding is not. If you live in a state with a patient-advocate intermediary, call the advocate first. If you do not, the submission has to do the work the advocate would have done.

About the author

Mark Henderson is a senior reviewer at Apellica, an independent insurance appeal preparation service headquartered at One World Trade Center, New York, NY 10007. Apellica is not a law firm and does not provide legal advice. Coverage across all 50 states. Contact: press@apellica.com, +1 (888) 777-6120.

References

• 45 CFR 147.136. ACA Internal Claims and Appeals and External Review.
• 29 CFR 2560.503-1. ERISA Claims Procedure.
• 42 CFR 422.592. Medicare Advantage Reconsideration by an Independent Entity.
• 42 CFR Part 422, Subpart M. Medicare Advantage Grievances and Appeals.
• 42 CFR Part 405. Original Medicare Appeals.
• Texas Insurance Code Chapter 4202. Independent Review of Adverse Determinations.
• New York Insurance Law Article 49. External Appeal.
• Illinois Health Carrier External Review Act, 215 ILCS 180.
• Massachusetts General Laws Chapter 176O. Office of Patient Protection.
• California Health and Safety Code Section 1374.30 et seq. DMHC Independent Medical Review.
• Connecticut General Statutes Title 38a. External Review.
• Connecticut Office of the Healthcare Advocate. ct.gov/oha.
• New Jersey Independent Health Care Appeals Program (IHCAP).
• CMS Center for Consumer Information and Insurance Oversight. cms.gov/CCIIO.
• HHS-Administered Federal External Review Process. externalappeal.com, +1 (888) 866-6205.
• NAIC Consumer Information Source. content.naic.org/consumer.htm.
• KFF state-by-state insurance tracker. kff.org/statedata.
• Patient Advocate Foundation. patientadvocate.org.
• Department of Labor EBSA. askebsa.dol.gov.
• Medicare Rights Center. medicarerights.org.
• ProPublica, "How to Fight Your Health Insurance Denial With an External Appeal," 2023.
• State Department of Insurance annual external-review reports (CT, CA DMHC, NY DFS, TX TDI, MA OPP, IL DOI, FL OIR, NJ DOBI, MD MIA, OR DCBS, VT DFR, WA OIC, WV OIC).